Cargando…
Effects of AST‐120 on muscle health and quality of life in chronic kidney disease patients: results of RECOVERY study
BACKGROUND: The prevalence of sarcopenia is increased with declining renal function. Elevated serum indoxyl sulfate levels are associated with poor skeletal muscle conditions. We aimed to determine the effects of AST‐120, the oral adsorbent of indoxyl sulfate, on sarcopenia and sarcopenia‐associated...
Autores principales: | Cha, Ran‐hui, Kang, Seok Hui, Han, Mi Yeun, An, Won Suk, Kim, Su‐Hyun, Kim, Jun Chul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818653/ https://www.ncbi.nlm.nih.gov/pubmed/34862753 http://dx.doi.org/10.1002/jcsm.12874 |
Ejemplares similares
-
Prediction of Patients Who Can Benefit from Oral Intestinal Sorbent AST-120
por: Cha, Ran-hui
Publicado: (2019) -
Indoxyl Sulfate Might Play a Role in Sarcopenia, While Myostatin Is an Indicator of Muscle Mass in Patients with Chronic Kidney Disease: Analysis from the RECOVERY Study
por: Lee, Su Mi, et al.
Publicado: (2022) -
AST-120 for the management of progression of chronic kidney disease
por: Schulman, Gerald, et al.
Publicado: (2014) -
Untargeted plasma and tissue metabolomics in rats with chronic kidney disease given AST-120
por: Velenosi, Thomas J., et al.
Publicado: (2016) -
Risk factors for progression of chronic kidney disease in the EPPIC trials and the effect of AST-120
por: Schulman, Gerald, et al.
Publicado: (2017)